- Monomorphic ventricular tachycardia due to protease inhibitor intoxication by atazanavir
-
Kim B, Kim KS
- KMID: 2416926
- Clin Exp Emerg Med.
- 2018 Jun;5(2):131-134.
- doi: 10.15441/ceem.17.229
Atazanavir is a protease inhibitor approved for use in combination with other antiretroviral drugs for the treatment of human immunodeficiency virus infection. Atazanavir and other protease inhibitors can sometimes induce... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Ritonavir-boosting on Atazanavir Discontinuation due to Jaundice in HIV-infected Koreans
-
Choe PG, Park WB, Song KH, Bang JH, Kim ES, Park SW, Kim HB, Kim NJ, Oh MD, Choe KW
- KMID: 2170367
- Infect Chemother.
- 2012 Jun;44(3):175-179.
- doi: 10.3947/ic.2012.44.3.175
BACKGROUND: Data regarding differences of intolerance between a ritonavir-unboosted and a ritonavir-boosted atazanavir regimen in HIV-infected Koreans is limited. MATERIALS AND METHODS: A review was conducted of the incidence of severe... -
- CITED
-
- Close
- SHARE
-
- Close
- Lipid Profile Changes after Switch to Atazanavir from other Protease Inhibitor-based Combined Antiretroviral Treatment in HIV-infected Korean
-
Baek JH, Song YG, Kim CO, Jeong SJ, Koo NS, Kim HW, Han SH, Choi JY, Kim JM
- KMID: 2170383
- Infect Chemother.
- 2012 Oct;44(5):377-381.
- doi: 10.3947/ic.2012.44.5.377
Dyslipidemia, one of the major disadvantages of use of protease inhibitor (PI), is a risk factor for cardiovascular disease in HIV-infected patients receiving antiretroviral treatment. Little is known about the... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical Trials
-
Choi JY, Sungkanuparph S, Anekthananon T, Sax P, DeJesus E, Edelstein , Nelson M, DeMorin J, Liu HC, Swamy R, Bahn J, Hwang S, Yang SY, Ng C, Piontkowsky D
- KMID: 2466435
- Infect Chemother.
- 2016 Sep;48(3):219-224.
- doi: 10.3947/ic.2016.48.3.219
The efficacy and safety of a single tablet regimen (STR) of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (E/C/F/TDF) were analyzed in Phase 3 clinical trials in antiretroviral therapy (ART)-naïve and ART-experienced Asian subjects... -
- CITED
-
- Close
- SHARE
-
- Close
- The Incidence and Clinical Characteristics of Acute Serum Creatinine Elevation more than 1.5 mg/dL among the Patients Treated with Tenofovir/Emtricitabine-containing HAART Regimens
-
Jin S, Kim MH, Park JH, Jung HJ, Lee HJ, Kim SW, Lee JM, Kim S, Chang HH
- KMID: 2170501
- Infect Chemother.
- 2015 Dec;47(4):239-246.
- doi: 10.3947/ic.2015.47.4.239
BACKGROUND: The combination of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) has been the first choice nucleoside reverse transcriptase inhibitor (NRTI) according to many reliable antiretroviral treatment (ART) guidelines because... -
- CITED
-
- Close
- SHARE
-
- Close
